TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Opus Genetics to Present at the J.P. Morgan 2026 Healthcare Conference

GlobeNewswire Inc. Logo GlobeNewswire Inc. By George Magrath, M.D.
Opus Genetics to Present at the J.P. Morgan 2026 Healthcare Conference

Opus Genetics, a clinical-stage biopharmaceutical company, will present at the J.P. Morgan 2026 Healthcare Conference. The company focuses on developing gene therapies for inherited retinal diseases, with seven AAV-based programs targeting various genetic mutations.

Insights
GOOG   positive

Currently above $3 trillion market cap


IRD   positive

The company is actively developing innovative gene therapies, has a robust pipeline of treatment programs, and is presenting at a major healthcare conference, indicating growth and potential